(Q36652514)

15 August 2017

1 reference

title

Pemphigus: a treatment update (English)

1 reference

15 August 2017

1 reference

Sarah E Dick

1

1 reference

15 August 2017

Victoria P Werth

series ordinal

2

1 reference

15 August 2017

publication date

1 November 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

39

1 reference

15 August 2017

issue

7

1 reference

15 August 2017

page(s)

591-599

1 reference

Pemphigus in the Mediterranean region of Turkey: a study of 148 cases.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

A unique form of endemic pemphigus in northern Colombia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Genetic factors in pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Treatment of pemphigus vulgaris and pemphigus foliaceus: experience with 71 patients over a 20 year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Pemphigus vulgaris with oral involvement: evaluation of two different systemic corticosteroid therapeutic protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

High-dose intravenous 'pulse' methylprednisone in the treatment of severe oropharyngeal pemphigus: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Dexamethasone pulse therapy in pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Steroid-pulse therapy in pemphigus vulgaris long term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

An evaluation of the usefulness of mycophenolate mofetil in pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

The use of chlorambucil with prednisone in the treatment of pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Successful treatment of recalcitrant pemphigus vulgaris and pemphigus vegetans with etanercept and carbon dioxide laser.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Rapid response of IgA pemphigus of the subcorneal pustular dermatosis subtype to treatment with adalimumab and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Keratinocyte acetylcholine receptors regulate cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

Pemphigus vulgaris antibody identifies pemphaxin. A novel keratinocyte annexin-like molecule binding acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

New approaches to the treatment of pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600972008

10.1080/08916930600972008

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference